Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 120
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we prevent the transmission of BRCA mutations?

Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

Activating brown fat to improve diabetes and obesity

Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

A novel approach to fight lung cancer progression

We are working with a protein that modulates the genetic information to generate different proteins from...

Backer Badge Funded